Clinical outcomes after cord blood transplantation
Originally presented March 28, 2019
Outcomes after umbilical cord blood transplantation have been reported similar to the ones after transplants using different stem cell sources. In this presentation, Dr. Filippo Milano shows how cord blood can be associated with a lower risk of relapse in patients with high risk hematological malignancies.
Furthermore, he presents exciting data regarding lower risk of Graft Versus Host Disease (GVHD) in patients receiving cord blood as a source of stem cells. These finding correlate with a higher likelihood of return to normal activities, with a corresponding improvement in quality of life.
View the webcast to learn some of the research team's key findings, including:
- The clinical outcomes in patients with residual disease undergoing transplantation
- The risk of chronic GVHD in patients undergoing cord blood transplantation
- Quality of life outcomes measured by return to school and work in patients undergoing transplantation using an alternative source of stem cells
Complete the form to view the webcast!
About Share the Science
Share the Science is a free webinar series designed to bring you powerful presentations by the top experts in cellular therapy. Generously supported by WellSky and Save the Cord Foundation, Share the Science webinars connect you to the world's most innovative and influential scientists, clinical researchers, and experts as they highlight the latest breakthroughs and most promising developments in cellular therapy.
Learn more about Save the Cord Foundation.